Ameritas Investment Partners’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-4,955
| Closed | -$255K | – | 3073 |
|
|
2022
Q3 | $255K | Buy |
4,955
+215
| +5% | +$8.89K | 0.01% | 953 |
|
|
2022
Q2 | $117K | Buy |
4,740
+707
| +18% | +$15.6K | 0.01% | 1402 |
|
|
2022
Q1 | $101K | Hold |
4,033
| – | – | ﹤0.01% | 1647 |
|
|
2021
Q4 | $147K | Hold |
4,033
| – | – | 0.01% | 1444 |
|
|
2021
Q3 | $69K | Hold |
4,033
| – | – | ﹤0.01% | 1941 |
|
|
2021
Q2 | $54K | Hold |
4,033
| – | – | ﹤0.01% | 2132 |
|
|
2021
Q1 | $207K | Sell |
4,033
-192
| -5% | -$11.6K | 0.01% | 1190 |
|
|
2020
Q4 | $262K | Hold |
4,225
| – | – | 0.01% | 993 |
|
|
2020
Q3 | $232K | Buy |
4,225
+296
| +8% | +$15.9K | 0.01% | 961 |
|
|
2020
Q2 | $226K | Buy |
3,929
+270
| +7% | +$14.7K | 0.01% | 960 |
|
|
2020
Q1 | $147K | Buy |
3,659
+150
| +4% | +$6.37K | 0.01% | 1063 |
|
|
2019
Q4 | $139K | Hold |
3,509
| – | – | 0.01% | 1312 |
|
|
2019
Q3 | $24K | Hold |
3,509
| – | – | ﹤0.01% | 2302 |
|
|
2019
Q2 | $33K | Buy |
3,509
+1,389
| +66% | +$16.1K | ﹤0.01% | 2156 |
|
|
2019
Q1 | $29K | Hold |
2,120
| – | – | ﹤0.01% | 2188 |
|
|
2018
Q4 | $23K | Hold |
2,120
| – | – | ﹤0.01% | 2273 |
|
|
2018
Q3 | $27K | Hold |
2,120
| – | – | ﹤0.01% | 2367 |
|
|
2018
Q2 | $28K | Hold |
2,120
| – | – | ﹤0.01% | 2326 |
|
|
2018
Q1 | $29K | Hold |
2,120
| – | – | ﹤0.01% | 2236 |
|
|
2017
Q4 | $13K | Hold |
2,120
| – | – | ﹤0.01% | 2677 |
|
|
2017
Q3 | $14K | Hold |
2,120
| – | – | ﹤0.01% | 2624 |
|
|
2017
Q2 | $20K | Hold |
2,120
| – | – | ﹤0.01% | 2459 |
|
|
2017
Q1 | $15K | Buy |
+2,120
| New | +$15.3K | ﹤0.01% | 2559 |
|
Other funds holding CCXI
Ameritas Investment Partners's CCXI Position: Q4 2022 in Review
Ameritas Investment Partners sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 4,955 shares — an estimated $255K sold.
Ameritas Investment Partners first reported a position in CCXI in Q1 2017 and held it in 23 quarters. The position peaked at $262K in Q4 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- Ameritas Investment Partners reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- Ameritas Investment Partners sold 4,955 ChemoCentryx, Inc. shares in Q4 2022, an estimated $255K.
- Ameritas Investment Partners first reported a position in ChemoCentryx, Inc. in Q1 2017 and held it in 23 quarters.
- Ameritas Investment Partners's ChemoCentryx, Inc. position peaked at $262K in Q4 2020.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on Ameritas Investment Partners's 13F filing for Q4 2022, filed 13 Feb 2023.